Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Comparative Study of the Efficacy of 10.0 mg Dequalinium Chloride (Fluomizin®) and 100 mg Clotrimazole (Canesten®) for the Treatment of Vulvovaginal Candidiasis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02242695
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:26.382889+00:00
Published At
2016-09-15T00:00:00+00:00
Record Updated At
2016-09-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Vulvovaginal Candidiasis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-09-15"
protocolSection.identificationModule.nctId
"NCT02242695"
protocolSection.identificationModule.officialTitle
"Comparative Study of the Efficacy of 10.0 mg Dequalinium Chloride (Fluomizin\u00ae) and 100 mg Clotrimazole (Canesten\u00ae) for the Treatment of Vulvovaginal Candidiasis"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Vulvovaginal Candidiasis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.